Bioinnovation Institute reaches DKK 1bn milestone

In just four years, Bioinnovation Institue (BII) has reached a significant milestone, as the life science incubator's former start-ups have surpassed DKK 1bn (USD 153.8m) in external financing.

Photo: Bioinnovation Institute / PR

The streets of Denmark have been paved with gold for biotech companies over the past few years, and a number of firms have gained historically large amounts from investors.

This can be felt at life science incubator Bioinnovation Institute (BII), which has recently surpassed a milestone that, according to CEO Jens Nielsen, demonstrates that the life science ecosystem is "on top form."

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs